Elevai Labs
ELAB
6 hedge funds and large institutions have $388K invested in Elevai Labs in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
5,322% more capital invested
Capital invested by funds: $7.16K → $388K (+$381K)
200% more funds holding
Funds holding: 2 → 6 (+4)
1.19% more ownership
Funds ownership: 0% → 1.2% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$405K |
| 2 |
Morgan Stanley
New York
|
+$192K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$190K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$25.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$10 |
ELAB Hedge Fund Activity: Q1 2026 in Review
6 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Elevai Labs (ELAB) for Q1 2026, worth a combined $388K — up 5,322% from $7.16K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ELAB positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $405K. The largest seller was Bank of America, cutting an estimated $10.
- 6 institutional investors held Elevai Labs (ELAB) as of Q1 2026, up from 2 in Q4 2025.
- Funds reported $388K of Elevai Labs stock for Q1 2026, up 5,322% quarter-over-quarter.
- 4 funds opened new Elevai Labs positions in Q1 2026 and 0 closed out, a net change of +4 holders.
- The largest Elevai Labs buyer in Q1 2026 was Jane Street, an estimated $405K added.
- The largest Elevai Labs seller in Q1 2026 was Bank of America, an estimated $10 sold.
Based on aggregated 13F filings for Q1 2026.